Logo

Decode to Raise $30M in Stock Offering

Jul 14, 2006

NEW YORK (GenomeWeb News) - Decode Genetics plans to raise $30 million in a common stock offering to new and existing institutional investors, the company said today.

 
Decode said it will sell 6 million shares at $5 apiece. The shares closed at $5.68 yesterday. The company expects net proceeds after expenses to be approximately $27.8 million.
 
Decode said it expects to close the transaction on or about July 18.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.